Revolution Medicines, Inc. (RVMD) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | -7.3% |
| FCF Growth (YoY) | 58.5% |
| Price / Book | 30.02 |
| Price / Sales | 506.40 |
| FCF Yield | -3.6% |
| Altman Z-Score | 32.37 (safe) |
| Sector P/E (Healthcare) | 21.6 |
RVMD overview · RVMD earnings · RVMD KPIs · RVMD investor relations · RVMD ownership · RVMD peers · RVMD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.